|
KLHL12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.852600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.930790E-01 |
| Normal-vs-Stage2 |
6.024400E-01 |
| Normal-vs-Stage3 |
1.512630E-01 |
| Normal-vs-Stage4 |
4.940200E-01 |
| Stage1-vs-Stage2 |
1.988990E-01 |
| Stage1-vs-Stage3 |
5.251700E-02 |
| Stage1-vs-Stage4 |
2.150400E-01 |
| Stage2-vs-Stage3 |
3.350600E-01 |
| Stage2-vs-Stage4 |
8.081000E-01 |
| Stage3-vs-Stage4 |
5.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.106400E-01 |
| Normal-vs-AfricanAmerican |
2.492200E-01 |
| Normal-vs-Asian |
9.368200E-01 |
| Caucasian-vs-AfricanAmerican |
6.291800E-02 |
| Caucasian-vs-Asian |
8.060200E-01 |
| AfricanAmerican-vs-Asian |
7.110800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.080800E-01 |
| Normal-vs-Female |
2.496000E-01 |
| Male-vs-Female |
9.885800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.155200E-01 |
| Normal-vs-Extreme_Weight |
2.182200E-01 |
| Normal-vs-Obese |
9.076800E-01 |
| Normal-vs-Extreme_Obese |
6.506800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.774040E-01 |
| Normal_Weight-vs-Obese |
5.792600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.025800E-01 |
| Extreme_Weight-vs-Obese |
3.646200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.590400E-01 |
| Obese-vs-Extreme_Obese |
6.321400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.985000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.314400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.860400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.077750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.191800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.349400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.365980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.508400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.381600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.214570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.229600E-01 |
| Normal-VS-Type2 PRCC |
4.379800E-02 |
| Normal-VS-KIRP CIMP |
7.161000E-01 |
| Normal-VS-Unclassified PRCC |
5.998600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.844100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.219400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.317830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.690000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.366400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.453200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.547800E-01 |
| Normal-vs-N1 |
8.038200E-02 |
| Normal-vs-N2 |
5.969000E-01 |
| N0-vs-N1 |
5.259800E-02 |
| N0-vs-N2 |
3.126600E-01 |
| N1-vs-N2 |
8.393200E-01 |
|
|
